PAK4 as a potential marker for poor response to immunotherapy in melanoma patients Read more about PAK4 as a potential marker for poor response to immunotherapy in melanoma patients
Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO) Read more about Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)
Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma Read more about Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma
A single-tube NGS assay for simultaneous detection of DNA and RNA biomarkers as a comprehensive solution for clinical management and guiding therapeutic intervention of Ph-like ALL patients Read more about A single-tube NGS assay for simultaneous detection of DNA and RNA biomarkers as a comprehensive solution for clinical management and guiding therapeutic intervention of Ph-like ALL patients
Deep phenotyping and spatial immune contexture characterization through a combined multiplex immunofluorescence ( mIF ) approach Read more about Deep phenotyping and spatial immune contexture characterization through a combined multiplex immunofluorescence ( mIF ) approach
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial. Read more about Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial.
Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort Read more about Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort
NGS assay for simultaneous screening of DNA and RNA provides a comprehensive solution guiding clinical management of ALL patients Read more about NGS assay for simultaneous screening of DNA and RNA provides a comprehensive solution guiding clinical management of ALL patients
Single-tube NGS profiling allows identification of molecular signature in ALL patients Read more about Single-tube NGS profiling allows identification of molecular signature in ALL patients
Landscape of known and novel myeloid neoplasia fusions identified by a multimodal comprehensive genomic profiling test in 789 patients Read more about Landscape of known and novel myeloid neoplasia fusions identified by a multimodal comprehensive genomic profiling test in 789 patients